TEXAS ENDOCRINOLOGY ASSOCIATION (EIN 010735690) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Principal Officer

Lindsay Bundrick Harrison MD

Phone

8475177225

Tax Period

2023-01-01 to 2023-12-31

TEXAS ENDOCRINOLOGY ASSOCIATION is a small nonprofit in the Community Improvement sector that reported $252K in total revenue in fiscal year 2023. Revenue decreased 8% compared to the prior year. The organization ran a surplus of $41K, a strong 16% operating margin.

Mission

TO PROMOTE THE HIGHEST STANDARD OF MEDICAL PRACTICE FOR PATIENTS WITH ENDOCRINE DISORDERS AND TO SERVE AS A REPRESENTATIVE SPOKESPERSON FOR PHYSICIANS IN THE CHAPTER TREATING PATIENTS WITH ENDOCRINE DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $251,672

Investment Income $0

Other Revenue $0

TOTAL REVENUE $251,672

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $210,444

TOTAL EXPENSES $210,444

Year-over-Year Comparison

	2023	2022	Change
Revenue	$251,672	$272,353	-0.1%
Expenses	$210,444	$234,069	-0.1%
Net Income	$41,228	$38,284	+0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Lindsay Bundrick Harrison MD	President	1.00	Officer Director	$0	$0	$0
Alberto Omar Chavez Velazquez	Vice President	1.00	Officer Director	$0	$0	$0
Vidhya Illuri MD FEAA	Treasurer	1.00	Officer Director	$0	$0	$0
Kathy Ann LaCivita MD FACP	PAST PRESIDENT	1.00	Director	$0	$0	$0
Ruchi Gaba MD FACE FEAA	Director	1.00	Director	$0	$0	$0
Daniel E Okorodudu MD	Director	1.00	Director	$0	$0	$0
Elizabeth Edrington King MD	Director	1.00	Director	$0	$0	$0
Arti Thangudu MD	Director	1.00	Director	$0	$0	$0
Jean Chen MD	Pres. Appointee	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$251,672	$210,444	$527,186	$41,228
2022	$272,353	$234,069	$477,235	$38,284
2021	$226,188	$189,595	$429,524	$36,593
2019	$211,084	$183,236	$383,357	$27,848

TEXAS ENDOCRINOLOGY ASSOCIATION